FOXO4-DRIvsKPV
FOXO4-DRI vs KPV — independent comparison of uses, administration, pricing across providers, and key differences. Last reviewed April 21, 2026.
Quick Verdict
Based on clinical evidence and real patient data
A D-amino acid retro-inverso peptide designed to disrupt the interaction between FOXO4 and p53 in senescent cells, triggering apoptosis of these 'zombie cells.' A first-in-class senolytic peptide with potential to clear senescent cell burden.
A tripeptide fragment derived from the C-terminus of alpha-melanocyte-stimulating hormone (α-MSH). KPV carries the anti-inflammatory properties of α-MSH without its melanogenic effects, making it a targeted tool for gut and systemic inflammation.
Best choice depends on your insurance, budget, and treatment history.Take the quiz to get a personalized recommendation.
FOXO4-DRI vs KPV: At a Glance
Full comparison across all key factors.
| Factor | FOXO4-DRI | KPVALLY PICK |
|---|---|---|
| Category | anti-aging | recovery |
| Also Known As | Senostatin, FOXO4-p53 DRI peptide | Lys-Pro-Val, Alpha-MSH tripeptide |
| Administration | Subcutaneous injection | Oral capsule or subcutaneous injection |
| Prescription | Required | Required |
| Providers | 2 providers | 3 providers✓ Better |
| Common Uses |
|
|
Data sourced from FDA prescribing information and peer-reviewed clinical trials. Prices reflect telehealth platform costs as of April 21, 2026. See our methodology.
Pricing by Provider
2 providers offer both FOXO4-DRI and KPV.
| Provider | FOXO4-DRI | KPV | Consultation | Lab Testing |
|---|---|---|---|---|
| $450/per-cycle | $130/monthly | Video Telehealth | Yes | |
| $550/per-cycle | $170/monthly | Video Telehealth | Yes | |
| Not offered | $145/monthly | Video Telehealth | Yes |
Key Differences
FOXO4-DRI
A D-amino acid retro-inverso peptide designed to disrupt the interaction between FOXO4 and p53 in senescent cells, triggering apoptosis of these 'zombie cells.' A first-in-class senolytic peptide with potential to clear senescent cell burden.
KPV
More ProvidersA tripeptide fragment derived from the C-terminus of alpha-melanocyte-stimulating hormone (α-MSH). KPV carries the anti-inflammatory properties of α-MSH without its melanogenic effects, making it a targeted tool for gut and systemic inflammation.
Which Is Right for You?
Choose FOXO4-DRIif…
- You want a anti-aging medication
- You prefer subcutaneous injection administration
- 2 providers available on our platform
- Your primary goal is senescent cell clearance
- Your primary goal is tissue rejuvenation
Choose KPVif…
- You want a recovery medication
- You prefer oral capsule or subcutaneous injection administration
- You want more provider options (3 available)
- Your primary goal is gut inflammation
- Your primary goal is ibd and crohn's support
Frequently Asked Questions
What is the difference between FOXO4-DRI and KPV?
Which is cheaper, FOXO4-DRI or KPV?
Can I switch from FOXO4-DRI to KPV?
Medical Disclaimer
This comparison is for informational purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider before starting, stopping, or changing any medication. Individual results may vary. The information presented reflects publicly available data and may not account for your specific health situation.